PBPIA
GRCL

Pivotal bioVenture Partners Investment Advisor’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Pivotal bioVenture Partners Investment Advisor’s Portfolio GRCL Stock Details GRCL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,375,000
Closed -$13.8M – 13
2023
Q4 		$13.8M Hold
1,375,000
– – 3.5% 6
2023
Q3 		$3.96M Buy
+1,375,000
New +$3.96M 1.58% 8